Objectives COVID-19 has been arguably the most important public health concern worldwide in 2020, and efforts are now escalating to suppress or eliminate its spread. In this …
Background A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly in Manaus, the capital of Amazonas state in northern Brazil. The attack rate there is an estimate of the …
YMJ Goërtz, M Van Herck, JM Delbressine… - ERJ open …, 2020 - Eur Respiratory Soc
Background Many patients with COVID-19 did not require hospitalisation, nor underwent COVID-19 testing. There is anecdotal evidence that patients with “mild” COVID-19 may …
Estimating the size of the coronavirus disease 2019 (COVID-19) pandemic and the infection severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is made …
K Sun, W Wang, L Gao, Y Wang, K Luo, L Ren, Z Zhan… - Science, 2021 - science.org
INTRODUCTION The role of transmission heterogeneities in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) dynamics remains unclear, particularly those …
TJ Ripperger, JL Uhrlaub, M Watanabe, R Wong… - Immunity, 2020 - cell.com
We conducted a serological study to define correlates of immunity against SARS-CoV-2. Compared to those with mild coronavirus disease 2019 (COVID-19) cases, individuals with …
P Galanis, I Vraka, D Fragkou, A Bilali… - Journal of Hospital …, 2021 - Elsevier
Summary Background Healthcare workers (HCWs) represent a high-risk population for infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Aim To …
JPA Ioannidis - Bulletin of the world health organization, 2021 - ncbi.nlm.nih.gov
Objective To estimate the infection fatality rate of coronavirus disease 2019 (COVID-19) from seroprevalence data. Methods I searched PubMed and preprint servers for COVID-19 …